RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
Hippocampal-amygdalo-ventricular atrophy score: Alzheimer disease detection using normative and pathological lifespan models
[EN] In this article, we present an innovative MRI-based method for Alzheimer disease (AD) detection and mild cognitive impairment (MCI) prognostic, using lifespan trajectories of brain structures. After a full screening of the most discriminant structures between AD and normal aging based on MRI volumetric analysis of 3,032 subjects, we propose a novel Hippocampal-Amygdalo-Ventricular Atrophy score (HAVAs) based on normative lifespan models and AD lifespan models. During a validation on three external datasets on 1,039 subjects, our approach showed very accurate detection (AUC >= 94%) of patients with AD compared to control subjects and accurate discrimination (AUC = 78%) between progressive MCI and stable MCI (during a 3-year follow-up). Compared to normative modeling, classical machine learning methods and recent state-of-the-art deep learning methods, our method demonstrated better classification performance. Moreover, HAVAs simplicity makes it fully understandable and thus well-suited for clinical practice or future pharmaceutical trials., UK Alzheimer's Society, Grant/Award Number: RF116; GlaxoSmithKline, Grant/Award Number: 6GKC; Leon Levy Foundation; NIMH, Grant/Award Numbers: R03MH096321, K23MH087770; ABIDE; U.K. Engineering and Physical Sciences Research Council, Grant/Award Number: GR/S21533/02; Canadian Institutes of Health Research, Grant/Award Number: MOP-34996; Human Brain Project, Grant/Award Number: PO1MHO52176-11; Alzheimer Drug Discovery Foundation; Alzheimer Association; National Health and Medical Research Council of Australia, Grant/Award Number: 1011689; Science Industry Endowment Fund; Common-wealth Scientific Industrial Research Organization; OASIS Brains Datasets, Grant/Award Numbers: P50 AG05681, P01 AG03991, R01 AG021910, P50 MH071616, U24 RR021382, R01 MH56584; NIH, Grant/Award Numbers: K01 AG030514, P30AG010129; National Institute of Biomedical Imaging and Bioengineering; National Institute on Aging; National Institutes of Health, Grant/Award Number: U01 AG024904; National Institute of Neurological Disorders and Stroke; National Institute of Mental Health; National Institute on Drug Abuse; National Institute of Child Health and Human Development, Grant/Award Number: HHSN275200900018C; Ministerio de Ciencia e Innovacion, Grant/Award Number: PID2020-118608RB-I00; French National Research Agency, Grant/Award Number: ANR-18-CE45-0013
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 PID2020-118608RB-I00
,
Agence Nationale de la Recherche / NHMRC Project Grants ANR-18-CE45-0013
,
Francia 1011689
,
National Health and Medical Research Council GR/S21533/02
,
Australia R01 AG021910
,
Engineering and Physical Sciences Research Council K01 AG030514
,
Reino Unido U24 RR021382
,
National Institutes of Health P50 MH071616
,
EEUU HHSN275200900018C
,
National Institutes of Health U01 AG024904
,
EEUU R01 MH56584
,
National Institutes of Health P01 AG03991
,
EEUU P50 AG05681
,
National Institutes of Health MOP34996
,
EEUU PO1MHO5217611
,
National Institutes of Health K23MH087770
,
EEUU R03MH096321